AAAAAA

   
Results: 1-13 |
Results: 13
Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids
Authors: Pettegrew, JW Panchalingam, K McClure, RJ Gershon, S Muenz, LR Levine, J
Citation: Jw. Pettegrew et al., Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids, BIPOL DIS, 3(4), 2001, pp. 189-201
Postprocessing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo P-31 brain spectra
Authors: Stanley, JA Pettegrew, JW
Citation: Ja. Stanley et Jw. Pettegrew, Postprocessing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo P-31 brain spectra, MAGN RES M, 45(3), 2001, pp. 390-396
Brain membrane phospholipid alterations in Alzheimer's disease
Authors: Pettegrew, JW Panchalingam, K Hamilton, RL McClure, RJ
Citation: Jw. Pettegrew et al., Brain membrane phospholipid alterations in Alzheimer's disease, NEUROCHEM R, 26(7), 2001, pp. 771-782
Brain metabolic effects of acute nicotine
Authors: Pettegrew, JW Panchalingam, K McClure, RJ Levine, J
Citation: Jw. Pettegrew et al., Brain metabolic effects of acute nicotine, NEUROCHEM R, 26(2), 2001, pp. 181-185
Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen
Authors: Pettegrew, JW Panchalingam, K Levine, J McClure, RJ Gershon, S Yao, JK
Citation: Jw. Pettegrew et al., Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen, BIOL PSYCHI, 49(5), 2001, pp. 444-453
Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression
Authors: Pettegrew, JW Levine, J McClure, RJ
Citation: Jw. Pettegrew et al., Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression, MOL PSYCHI, 5(6), 2000, pp. 616-632
Molecular insights into neurodevelopmental and neurodegenerative diseases
Authors: Pettegrew, JW Klunk, WE Panchalingam, K McClure, RJ Stanley, JA
Citation: Jw. Pettegrew et al., Molecular insights into neurodevelopmental and neurodegenerative diseases, BRAIN RES B, 53(4), 2000, pp. 455-469
Stability of CSF metabolites measured by proton NMR
Authors: Levine, J Panchalingam, K McClure, RJ Gershon, S Pettegrew, JW
Citation: J. Levine et al., Stability of CSF metabolites measured by proton NMR, J NEURAL TR, 107(7), 2000, pp. 843-848
Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part I
Authors: Stanley, JA Pettegrew, JW Keshavan, MS
Citation: Ja. Stanley et al., Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part I, BIOL PSYCHI, 48(5), 2000, pp. 357-368
Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part II
Authors: Keshavan, MS Stanley, JA Pettegrew, JW
Citation: Ms. Keshavan et al., Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part II, BIOL PSYCHI, 48(5), 2000, pp. 369-380
Increased cerebrospinal fluid glutamine levels in depressed patients
Authors: Levine, J Panchalingam, K Rapoport, A Gershon, S McClure, RJ Pettegrew, JW
Citation: J. Levine et al., Increased cerebrospinal fluid glutamine levels in depressed patients, BIOL PSYCHI, 47(7), 2000, pp. 586-593
Landmark-based morphometric analysis of first-episode schizophrenia
Authors: DeQuardo, JR Keshavan, MS Bookstein, FL Bagwell, WW Green, WDK Sweeney, JA Haas, GL Tandon, R Schooler, NR Jay, W Pettegrew, JW
Citation: Jr. Dequardo et al., Landmark-based morphometric analysis of first-episode schizophrenia, BIOL PSYCHI, 45(10), 1999, pp. 1321-1328
Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4
Authors: Klunk, WE Panchalingam, K McClure, RJ Stanley, JA Pettegrew, JW
Citation: We. Klunk et al., Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4, NEUROBIOL A, 19(6), 1998, pp. 511-515
Risultati: 1-13 |